Osteoarthritis: New Insights. Part 2: Treatment Approaches
Top Cited Papers
Open Access
- 7 November 2000
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 133 (9) , 726-737
- https://doi.org/10.7326/0003-4819-133-9-200011070-00015
Abstract
Osteoarthritis is the most common form of arthritis, affecting millions of people in the United States. It is a complex disease whose etiology bridges biomechanics and biochemistry. Evidence is growing for the role of systemic factors, such as genetics, diet, estrogen use, and bone density, and local biomechanical factors, such as muscle weakness, obesity, and joint laxity. These risk factors are particularly important in the weight-bearing joints, and modifying them may help prevent osteoarthritis-related pain and disability. Major advances in management to reduce pain and disability are yielding a panoply of available treatments ranging from nutriceuticals to chondrocyte transplantation, new oral anti-inflammatory medications, and health education. This article is part 2 of a two-part summary of a National Institutes of Health conference that brought together experts in osteoarthritis from diverse backgrounds and provided a multidisciplinary and comprehensive summary of recent advances in the prevention of osteoarthritis onset, progression, and disability. Part 2 focuses on treatment approaches; evidence for the efficacy of commonly used oral therapies is reviewed and information on alternative therapies, including nutriceuticals and acupuncture, is presented. Biomechanical interventions, such as exercise and bracing, and behavioral interventions directed toward enhancing self-management are reviewed. Current surgical approaches are described and probable future biotechnology-oriented approaches to treatment are suggested.Keywords
This publication has 47 references indexed in Scilit:
- Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitroOsteoarthritis and Cartilage, 1998
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998
- Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbitOsteoarthritis and Cartilage, 1998
- Anti-inflammatory activity of chondroitin sulfateOsteoarthritis and Cartilage, 1998
- Acetaminophen and Other Risk Factors for Excessive Warfarin AnticoagulationJAMA, 1998
- Acetaminophen Toxicity in an Urban County HospitalNew England Journal of Medicine, 1997
- Prevention of Peptic Ulcer and Dyspeptic Symptoms with Omeprazole in Patients Receiving Continuous Non-Steroidal Anti-Inflammatory Drug Therapy: A Nordic Multicentre StudyScandinavian Journal of Gastroenterology, 1996
- Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly PersonsAnnals of Internal Medicine, 1988
- Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory AgentsMedicine, 1984
- Inhibition of human elastase from polymorphonuclear leucocytes by a glycosaminoglycan polysulfate (Arteparon®)Biochemical Pharmacology, 1980